Výsledky vyhledávání

Akademický článek

Autor: Safroneeva E; Tillotts Pharma AG, Rheinfelden, Switzerland.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Thorne H; Tillotts Pharma AG, Rheinfelden, Switzerland., Gerstner O; Tillotts Pharma AG, Rheinfelden, Switzerland., Laoun R; Tillotts Pharma AG, Rheinfelden, Switzerland.

Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Jun 21. Date of Electronic Publication: 2024 Jun 21.

Zobrazit plný text záznamu

Akademický článek

Lack of Benefit for Early Escalation to Advanced Therapies in Ulcerative Colitis: Critical Appraisal of Current Evidence.

Autor: Burisch J; Gastro Unit, Medical Division, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark., Safroneeva E; Tillotts Pharma AG, Rheinfelden, Switzerland.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Laoun R; Tillotts Pharma AG, Rheinfelden, Switzerland., Ma C; Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2023 Dec 30; Vol. 17 (12), pp. 2002-2011.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of Induction.

Autor: D'Haens G; Inflammatory Bowel Disease Centre, Academic Medical Center, Amsterdam, The Netherlands., Safroneeva E; Medical Affairs, Tillotts Pharma AG, Rheinfelden, Switzerland., Thorne H; Medical Affairs, Tillotts Pharma AG, Rheinfelden, Switzerland., Laoun R; Medical Affairs, Tillotts Pharma AG, Rheinfelden, Switzerland.

Publikováno v: Inflammatory intestinal diseases [Inflamm Intest Dis] 2023 Jun 21; Vol. 8 (2), pp. 51-59. Date of Electronic Publication: 2023 Jun 21 (Print Publication: 2023).

Zobrazit plný text záznamu

Akademický článek

Medication Formulation Preference of Mild and Moderate Ulcerative Colitis Patients: a European Survey.

Autor: Hébuterne X; Gastro-entérologie et Nutrition Clinique, CHU de Nice, Université Côte d'Azur, Nice, France., Vavricka SR; Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland., Thorne HC; Tillotts Pharma AG, Rheinfelden, Switzerland., MacKenzie-Smith L; Tillotts Pharma AG, Rheinfelden, Switzerland., Laoun R; Tillotts Pharma AG, Rheinfelden, Switzerland., Burisch J; Gastrounit, Medical Division, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.

Publikováno v: Inflammatory intestinal diseases [Inflamm Intest Dis] 2023 May 12; Vol. 8 (1), pp. 41-49. Date of Electronic Publication: 2023 May 12 (Print Publication: 2023).

Zobrazit plný text záznamu

Akademický článek

Albumin-based solution is the ideal post-thawing suspension medium for cord blood hematopoietic stem cells: A stability and proliferative evaluation.

Autor: Lachica CA; Advanced Cell Therapy Core, Sidra Medicine, Doha, Qatar., Miele MJ; Advanced Cell Therapy Core, Sidra Medicine, Doha, Qatar., Herrera SM; Advanced Cell Therapy Core, Sidra Medicine, Doha, Qatar., Elanbari M; Advanced Cell Therapy Core, Sidra Medicine, Doha, Qatar., Deola S; Advanced Cell Therapy Core, Sidra Medicine, Doha, Qatar., Saleh A; Pediatric Oncology and Hematology Division, Sidra Medicine, Doha, Qatar., Ejaz A; Pediatric Oncology and Hematology Division, Sidra Medicine, Doha, Qatar., Aftab S; Advanced Cell Therapy Core, Sidra Medicine, Doha, Qatar., Olagunju D; Birth Center II and Women's Special Care, Sidra Medicine, Doha, Qatar., Laoun R; Birth Center II and Women's Special Care, Sidra Medicine, Doha, Qatar., Cugno C; Advanced Cell Therapy Core, Sidra Medicine, Doha, Qatar.; Pediatric Oncology and Hematology Division, Sidra Medicine, Doha, Qatar.

Publikováno v: Transfusion [Transfusion] 2023 May; Vol. 63 (5), pp. 1050-1059. Date of Electronic Publication: 2023 Apr 10.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání